Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. / Diener, Hans Christoph; Tassorelli, Cristina; Dodick, David W.; Silberstein, Stephan D.; Lipton, Richard B.; Ashina, Messoud; Becker, Werner J.; Ferrari, Michel D.; Goadsby, Peter J.; Pozo-Rosich, Patricia; Wang, Shuu Jiun; Houle, Timothy T.; Hoek, Thomas C.van den; Martinelli, Daniele; Terwindt, Gisela M.; on behalf of the International Headache Society Clinical Trials Committee.

I: Cephalalgia, Bind 40, Nr. 10, 2020, s. 1026-1044.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Diener, HC, Tassorelli, C, Dodick, DW, Silberstein, SD, Lipton, RB, Ashina, M, Becker, WJ, Ferrari, MD, Goadsby, PJ, Pozo-Rosich, P, Wang, SJ, Houle, TT, Hoek, TCVD, Martinelli, D, Terwindt, GM & on behalf of the International Headache Society Clinical Trials Committee 2020, 'Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults', Cephalalgia, bind 40, nr. 10, s. 1026-1044. https://doi.org/10.1177/0333102420941839

APA

Diener, H. C., Tassorelli, C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., Wang, S. J., Houle, T. T., Hoek, T. C. V. D., Martinelli, D., Terwindt, G. M., & on behalf of the International Headache Society Clinical Trials Committee (2020). Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia, 40(10), 1026-1044. https://doi.org/10.1177/0333102420941839

Vancouver

Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M o.a. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia. 2020;40(10):1026-1044. https://doi.org/10.1177/0333102420941839

Author

Diener, Hans Christoph ; Tassorelli, Cristina ; Dodick, David W. ; Silberstein, Stephan D. ; Lipton, Richard B. ; Ashina, Messoud ; Becker, Werner J. ; Ferrari, Michel D. ; Goadsby, Peter J. ; Pozo-Rosich, Patricia ; Wang, Shuu Jiun ; Houle, Timothy T. ; Hoek, Thomas C.van den ; Martinelli, Daniele ; Terwindt, Gisela M. ; on behalf of the International Headache Society Clinical Trials Committee. / Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. I: Cephalalgia. 2020 ; Bind 40, Nr. 10. s. 1026-1044.

Bibtex

@article{a024bdeb39444367ad715cf62c8530b3,
title = "Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults",
abstract = "Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. Advances in drugs, devices, and biologicals, as well as novel trial designs, have prompted several updates over the nearly 30 years since, including most recently the Guidelines for controlled trials of preventive treatment of chronic migraine (2018), the Guidelines for controlled trials of acute treatment of migraine attacks in adults (2019), and Guidelines for controlled trials of preventive treatment of migraine in children and adolescents (2019). The present update incorporates findings from new research and is intended to optimize the design of controlled trials of preventive pharmacological treatment of episodic migraine in adults. A guideline for clinical trials with devices will be published separately.",
author = "Diener, {Hans Christoph} and Cristina Tassorelli and Dodick, {David W.} and Silberstein, {Stephan D.} and Lipton, {Richard B.} and Messoud Ashina and Becker, {Werner J.} and Ferrari, {Michel D.} and Goadsby, {Peter J.} and Patricia Pozo-Rosich and Wang, {Shuu Jiun} and Houle, {Timothy T.} and Hoek, {Thomas C.van den} and Daniele Martinelli and Terwindt, {Gisela M.} and {on behalf of the International Headache Society Clinical Trials Committee}",
year = "2020",
doi = "10.1177/0333102420941839",
language = "English",
volume = "40",
pages = "1026--1044",
journal = "Cephalalgia",
issn = "0800-1952",
publisher = "SAGE Publications",
number = "10",

}

RIS

TY - JOUR

T1 - Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults

AU - Diener, Hans Christoph

AU - Tassorelli, Cristina

AU - Dodick, David W.

AU - Silberstein, Stephan D.

AU - Lipton, Richard B.

AU - Ashina, Messoud

AU - Becker, Werner J.

AU - Ferrari, Michel D.

AU - Goadsby, Peter J.

AU - Pozo-Rosich, Patricia

AU - Wang, Shuu Jiun

AU - Houle, Timothy T.

AU - Hoek, Thomas C.van den

AU - Martinelli, Daniele

AU - Terwindt, Gisela M.

AU - on behalf of the International Headache Society Clinical Trials Committee

PY - 2020

Y1 - 2020

N2 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. Advances in drugs, devices, and biologicals, as well as novel trial designs, have prompted several updates over the nearly 30 years since, including most recently the Guidelines for controlled trials of preventive treatment of chronic migraine (2018), the Guidelines for controlled trials of acute treatment of migraine attacks in adults (2019), and Guidelines for controlled trials of preventive treatment of migraine in children and adolescents (2019). The present update incorporates findings from new research and is intended to optimize the design of controlled trials of preventive pharmacological treatment of episodic migraine in adults. A guideline for clinical trials with devices will be published separately.

AB - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. Advances in drugs, devices, and biologicals, as well as novel trial designs, have prompted several updates over the nearly 30 years since, including most recently the Guidelines for controlled trials of preventive treatment of chronic migraine (2018), the Guidelines for controlled trials of acute treatment of migraine attacks in adults (2019), and Guidelines for controlled trials of preventive treatment of migraine in children and adolescents (2019). The present update incorporates findings from new research and is intended to optimize the design of controlled trials of preventive pharmacological treatment of episodic migraine in adults. A guideline for clinical trials with devices will be published separately.

U2 - 10.1177/0333102420941839

DO - 10.1177/0333102420941839

M3 - Journal article

C2 - 32722936

AN - SCOPUS:85088843506

VL - 40

SP - 1026

EP - 1044

JO - Cephalalgia

JF - Cephalalgia

SN - 0800-1952

IS - 10

ER -

ID: 258775649